المؤلفون: Pfister, Christian, Gravis, Gwenaelle, Flechon, Aude, Chevreau, Christine, Mahammedi, Hakim, Laguerre, Brigitte, Guillot, Aline, Joly, Florence, Soulie, Michel, Allory, Yves, Harter, Valentin, Culine, Stéphane, Pignot, Géraldine, Fendler, Jean Philippe, Guy, Laurent, Verhoest, Grégory, Mottet, Nicolas, Doerfler, Arnaud, Abadie Lacourtoisie, Sophie, Azzouzi, Abde Rahmene, Mongiat, Pierre, Geoffrois, Lionnel, Eschwege, Pascal, Di Fiore, Frédéric, Roubaud, Guilhem, Hoepffner, Jean Luc, Barthelemy, Philippe, Lang, Hervé, Voog, Eric, Mandron, Eric, Tourani, Jean Marc, Serrate, Camille, Colau, Alexandre, Saldana, Carolina, de la Taille, Alexandre, Nguyen, Thierry, Kleinclauss, François, Loriot, Yohan, Irani, Jacques, Eymard, Jean Christophe, Larre, Stéphane, Huillard, Olivier, Zerbib, Marc, Rolland, Frédéric, Rigaud, Jérôme, Houede, Nadine, Droupy, Stéphane, Malouf, Georgina, Roupret, Morgan, Vieillot, Sabine, Letang, Nicolas, Lharidon, Tiffen, Gaschignard, Nicolas, Hilgers, Werner, Davin, Jean Louis

المساهمون: Hôpital Charles Nicolle Rouen, CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Centre d'Investigation Clinique CHU Rouen (CIC Rouen), Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Département cancer environnement (Centre Léon Bérard - Lyon), Centre Léon Bérard Lyon, IUCTO, ICR, TOULOUSE, France, Centre Jean Perrin Clermont-Ferrand (UNICANCER/CJP), UNICANCER, CRLCC Eugène Marquis (CRLCC), Institut de Cancérologie de la Loire Lucien Neuwirth, Centre Hospitalier Universitaire de Saint-Etienne CHU Saint-Etienne (CHU ST-E), Centre Régional de Lutte contre le Cancer François Baclesse Caen (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Chirurgie Générale et Digestive Rangueil, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut Curie - Saint Cloud (ICSC), Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service Urologie CHU Clermont-ferrand, Pôle RHEUNNIRS CHU Clermont-Ferrand, CHU Gabriel Montpied Clermont-Ferrand, CHU Clermont-Ferrand-CHU Clermont-Ferrand-CHU Gabriel Montpied Clermont-Ferrand, CHU Clermont-Ferrand-CHU Clermont-Ferrand, Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Pontchaillou, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Université de Bourgogne (UB), Service d'Urologie CHU Caen, Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Institut de Cancérologie de Lorraine - Alexis Vautrin Nancy (UNICANCER/ICL), Centre de Recherche en Automatique de Nancy (CRAN), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Normandie Université (NU), Université de Rouen Normandie (UNIROUEN), Institut Bergonié Bordeaux, Institut de Cancérologie de Strasbourg Europe (ICANS), Les Hôpitaux Universitaires de Strasbourg (HUS), Clinique Victor Hugo Le Mans, Université Gustave Eiffel - UFR Sciences humaines et sociales (UGE UFR SHS), Université Gustave Eiffel, Groupe Hospitalier Diaconesses Croix Saint-Simon, French National Cancer Institute

المصدر: ISSN: 1470-2045.

مصطلحات موضوعية: MESH: Adult, MESH: Humans, MESH: Adolescent, MESH: Urinary Bladder Neoplasms, MESH: Cisplatin, MESH: Vinblastine, MESH: Methotrexate, MESH: Carcinoma, Transitional Cell, MESH: Gemcitabine, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Doxorubicin, MESH: Deoxycytidine, MESH: Neoadjuvant Therapy, MESH: Muscles, MESH: Male, MESH: Female, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/38142702; PUBMED: 38142702

الاتاحة: https://hal.science/hal-04839012
https://doi.org/10.1016/S1470-2045(23)00587-9

المؤلفون: Culine, Stéphane, Harter, Valentin, Gravis, Gwenaelle, Fléchon, Aude, Chevreau, Christine, Mahammedi, Hakim, Laguerre, Brigitte, Guillot, Aline, Joly, Florence, Abadie-Lacourtoisie, Sophie, Geoffrois, Lionnel, Di Fiore, Frederic, Roubaud, Guilhem, Barthélémy, Philippe, Voog, Eric, Emambux, Sheik, Serrate, Camille, Saldana, Carolina, Hon, Thierry Nguyen Tan, Loriot, Yohann, Eymard, Jean-Christophe, Huillard, Olivier, Rolland, Frédéric, Houédé, Nadine, Spano, Jean-Philippe, Demery, Mounira El, Vieillot, Sabine, L'Haridon, Tifenn, Hilgers, Werner, Allory, Yves, Pfister, Christian

المساهمون: Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Régional de Lutte contre le Cancer François Baclesse Caen (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Département cancer environnement (Centre Léon Bérard - Lyon), Centre Léon Bérard Lyon, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Jean Perrin Clermont-Ferrand (UNICANCER/CJP), UNICANCER, Département d'oncologie médicale Rennes, CRLCC Eugène Marquis (CRLCC), UNICANCER-UNICANCER, Institut de Cancérologie de la Loire Lucien Neuwirth, Centre Hospitalier Universitaire de Saint-Etienne CHU Saint-Etienne (CHU ST-E), Institut de Cancérologie de l'Ouest Angers/Nantes (UNICANCER/ICO), Institut de Cancérologie de Lorraine - Alexis Vautrin Nancy (UNICANCER/ICL), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Hôpital Charles Nicolle Rouen, CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Institut Bergonié Bordeaux, Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Clinique Victor Hugo Le Mans, Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie ), Groupe Hospitalier Diaconesses Croix Saint-Simon, CHU Henri Mondor Créteil, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Jean Godinot Reims, Sorbonne Université (SU), Hôpital Cochin AP-HP, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Institut Sainte Catherine Avignon, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Centre d'Investigation Clinique CHU Rouen (CIC Rouen), Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: ISSN: 1558-7673 ; Clinical Genitourinary Cancer ; https://hal.science/hal-03625944 ; Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩.

مصطلحات موضوعية: Cisplatin-based chemotherapy, Neoadjuvant treatment, Pathological complete response, Pathological downstaging, Perioperative chemotherapy, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Chemotherapy, Adjuvant, MESH: Methotrexate, MESH: Muscles, MESH: Neoadjuvant Therapy, MESH: Retrospective Studies, MESH: Urinary Bladder Neoplasms, MESH: Vinblastine, MESH: Cisplatin, MESH: Cystectomy, MESH: Doxorubicin, MESH: Humans, MESH: Kidney, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology

Relation: info:eu-repo/semantics/altIdentifier/pmid/34602349; PUBMED: 34602349; WOS: 000731363100020

الاتاحة: https://hal.science/hal-03625944
https://hal.science/hal-03625944v1/document
https://hal.science/hal-03625944v1/file/S1558767321001622.pdf
https://doi.org/10.1016/j.clgc.2021.08.005

المؤلفون: Rullier, Eric, Vendrely, Véronique, Asselineau, Julien, Rouanet, Philippe, Tuech, Jean-Jacques, Valverde, Alain, de Chaisemartin, Cecile, Rivoire, Michel, Trilling, Bertrand, Jafari, Mehrdad, Portier, Guillaume, Meunier, Bernard, Sieleznieff, Igor, Bertrand, Martin, Marchal, Frédéric, Dubois, Anne, Pocard, Marc, Rullier, Anne, Smith, Denis, Frulio, Nora, Frison, Eric, Denost, Quentin

المصدر: ISSN: 2468-1253 ; The Lancet Gastroenterology & Hepatology ; https://hal.umontpellier.fr/hal-03350581 ; The Lancet Gastroenterology & Hepatology, 2020, 5 (5), pp.465-474. ⟨10.1016/S2468-1253(19)30410-8⟩.

مصطلحات موضوعية: MESH: Adult, MESH: Aged, MESH: Middle Aged, MESH: Neoadjuvant Therapy, MESH: Neoplasm Metastasis, MESH: Neoplasm Recurrence, Local, MESH: Neoplasm Staging, MESH: Organ Sparing Treatments, MESH: Proctectomy, MESH: Proportional Hazards Models, MESH: Prospective Studies, MESH: Rectal Neoplasms, 80 and over, MESH: Survival Rate, MESH: Chemoradiotherapy, Adjuvant, MESH: Disease-Free Survival, MESH: Female, MESH: Humans, MESH: Intention to Treat Analysis, MESH: Kaplan-Meier Estimate, MESH: Male, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery

Relation: info:eu-repo/semantics/altIdentifier/pmid/32043980; hal-03350581; https://hal.umontpellier.fr/hal-03350581; PUBMED: 32043980

الاتاحة: https://hal.umontpellier.fr/hal-03350581
https://doi.org/10.1016/S2468-1253(19)30410-8

المؤلفون: van Berckelaer, C., Rypens, C., van Dam, P., Pouillon, L., Parizel, M., Schats, K., Kockx, M., Tjalma, W., Vermeulen, P., van Laere, S., Bertucci, F., Colpaert, C., Dirix, L.

المساهمون: Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Department of Medical Oncology, St-Augustinus

المصدر: ISSN: 1465-5411.

مصطلحات موضوعية: Immune checkpoint modulators, Immune response, Inflammatory breast cancer (IBC), Programmed death-ligand 1 (PD-L1), Stromal tumour-infiltrating lymphocytes (sTIL), MESH: Adult, MESH: Aged, 80 and over, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: B7-H1 Antigen, MESH: CD8-Positive T-Lymphocytes, MESH: Chemotherapy, Adjuvant, MESH: Disease-Free Survival, MESH: Female, MESH: Humans, MESH: Inflammatory Breast Neoplasms, MESH: Lymphocytes, Tumor-Infiltrating, MESH: Mastectomy, MESH: Middle Aged, MESH: Neoadjuvant Therapy, MESH: Prognosis, MESH: Stromal Cells, MESH: Survival Analysis, [SDV]Life Sciences [q-bio], [SDV.BC]Life Sciences [q-bio]/Cellular Biology

Relation: info:eu-repo/semantics/altIdentifier/pmid/30777104; hal-02533387; https://hal.science/hal-02533387; https://hal.science/hal-02533387/document; https://hal.science/hal-02533387/file/13058_2019_Article_1108.pdf; PUBMED: 30777104; PUBMEDCENTRAL: PMC6380068

الاتاحة: https://hal.science/hal-02533387
https://hal.science/hal-02533387/document
https://hal.science/hal-02533387/file/13058_2019_Article_1108.pdf
https://doi.org/10.1186/s13058-019-1108-1

المؤلفون: Viala, Marie, Chiba, Akiko, Thèzenas, Simon, Delmond, Laure, Lamy, Pierre-Jean, Mott, Sarah, L, Schroeder, Mary, C, Thomas, Alexandra, Jacot, William

المساهمون: Département d'oncologie Médicale, CRLCC Val d'Aurelle - Paul Lamarque, Wake Forest University, Unité de biostatistiques, Département de chirurgie, Clinique Médicale Beausoleil, University of Iowa Iowa City, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)

المصدر: ISSN: 1471-2407.

مصطلحات موضوعية: Neo-adjuvant breast cancer, Vitamin D, pCR, MESH: Breast Neoplasms, MESH: Female, MESH: Humans, MESH: Middle Aged, MESH: Neoadjuvant Therapy, MESH: Recurrence, MESH: Retrospective Studies, MESH: Vitamin D, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

Relation: info:eu-repo/semantics/altIdentifier/pmid/30060745; hal-02292914; https://hal.umontpellier.fr/hal-02292914; https://hal.umontpellier.fr/hal-02292914/document; https://hal.umontpellier.fr/hal-02292914/file/document%281%29.pdf; PUBMED: 30060745; PUBMEDCENTRAL: PMC6066931

الاتاحة: https://hal.umontpellier.fr/hal-02292914
https://hal.umontpellier.fr/hal-02292914/document
https://hal.umontpellier.fr/hal-02292914/file/document%281%29.pdf
https://doi.org/10.1186/s12885-018-4686-x

المؤلفون: Nessrine Souai, Laetitia Shintu, Fabrice Tranchida, Amor Mosbah, Farhat Ben Ayed, Henda Raies, Ameur Cherif, Sonia Mezrioui, Oumaima Zidi, Soumaya Kouidhi, Amel Mezlini, Jean-Marc Sabatier

المساهمون: Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Molecules, Vol 26, Iss 2266, p 2266 (2021)
Molecules
Molecules, MDPI, 2021, 26 (8), pp.2266. ⟨10.3390/molecules26082266⟩
Molecules, 2021, 26 (8), pp.2266. ⟨10.3390/molecules26082266⟩
Volume 26
Issue 8

مصطلحات موضوعية: Oncology, Male, Proton Magnetic Resonance Spectroscopy, Pharmaceutical Science, Gut flora, medicine.disease_cause, Analytical Chemistry, Feces, 0302 clinical medicine, MESH: Least-Squares Analysis, Drug Discovery, MESH: Metabolomics, metabolites, 0303 health sciences, MESH: Proton Magnetic Resonance Spectroscopy, Principal Component Analysis, MESH: Middle Aged, biology, MESH: Feces, Discriminant Analysis, dysbiosis, Middle Aged, metabolomics, Neoadjuvant Therapy, 3. Good health, Chemistry (miscellaneous), 030220 oncology & carcinogenesis, Metabolome, Molecular Medicine, Female, MESH: Biomarkers, Tumor, MESH: Metabolome, Metabolic Networks and Pathways, medicine.medical_specialty, MESH: Neoadjuvant Therapy, [SDV.CAN]Life Sciences [q-bio]/Cancer, Breast Neoplasms, Article, lcsh:QD241-441, 03 medical and health sciences, Breast cancer, Metabolomics, lcsh:Organic chemistry, Internal medicine, medicine, MESH: Carbon-13 Magnetic Resonance Spectroscopy, Biomarkers, Tumor, Humans, Physical and Theoretical Chemistry, Carbon-13 Magnetic Resonance Spectroscopy, Least-Squares Analysis, MESH: Fatty Acids, Volatile, 030304 developmental biology, MESH: Principal Component Analysis, MESH: Humans, gut microbiota, business.industry, breast cancer (BC), Organic Chemistry, Cancer, MESH: Discriminant Analysis, biomarkers, MESH: ROC Curve, Omics, medicine.disease, biology.organism_classification, Fatty Acids, Volatile, MESH: Male, ROC Curve, MESH: Metabolic Networks and Pathways, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, business, Carcinogenesis, Dysbiosis, MESH: Female, MESH: Breast Neoplasms

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1639a502db9cdd2e749db857d62119a
https://www.mdpi.com/1420-3049/26/8/2266

المؤلفون: Rouanet, P, Rivoire, M, Gourgou, S, Lelong, B, Rullier, E, Jafari, M, Mineur, L, Pocard, M, Faucheron, J, Dravet, F, Pezet, D, Fabre, J, Bresler, L, Balosso, J, Lemanski, C

المساهمون: Institut régional de Cancérologie de Montpellier (ICM), Centre Léon Bérard Lyon, Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), CHU Bordeaux, Centre Régional de Lutte contre le Cancer Oscar Lambret Lille (UNICANCER/Lille), Université de Lille-UNICANCER, Institut Sainte Catherine Avignon, INSERM UMR-S 606, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, PRES Sorbonne Paris-Cité, and Université Paris Denis Diderot, Université Paris Diderot - Paris 7 (UPD7), Centre Hospitalier Universitaire CHU Grenoble (CHUGA), Centre René Gauducheau, CRLCC René Gauducheau, CHU Clermont-Ferrand, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)

المصدر: ISSN: 0007-1323.

مصطلحات موضوعية: MESH: Adenocarcinoma, MESH: Anal Canal, MESH: Disease-Free Survival, MESH: Humans, MESH: Kaplan-Meier Estimate, MESH: Margins of Excision, MESH: Neoadjuvant Therapy, MESH: Rectal Neoplasms, MESH: Survival Analysis, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/33640922; hal-03657636; https://hal.science/hal-03657636; PUBMED: 33640922

الاتاحة: https://hal.science/hal-03657636
https://doi.org/10.1093/bjs/znaa010

المؤلفون: Zidi, Oumaima, Souai, Nessrine, Raies, Henda, Ben Ayed, Farhat, Mezlini, Amel, Mezrioui, Sonia, Tranchida, Fabrice, Sabatier, Jean-Marc, Mosbah, Amor, Cherif, Ameur, Shintu, Laetitia, Kouidhi, Soumaya

المساهمون: Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)

المصدر: ISSN: 1420-3049 ; Molecules ; https://hal-amu.archives-ouvertes.fr/hal-03358035 ; Molecules, MDPI, 2021, 26 (8), pp.2266. ⟨10.3390/molecules26082266⟩.

مصطلحات موضوعية: biomarkers, breast cancer (BC), dysbiosis, gut microbiota, metabolites, metabolomics, MESH: Biomarkers, Tumor, MESH: Breast Neoplasms, MESH: Metabolic Networks and Pathways, MESH: Metabolome, MESH: Metabolomics, MESH: Middle Aged, MESH: Neoadjuvant Therapy, MESH: Principal Component Analysis, MESH: Proton Magnetic Resonance Spectroscopy, MESH: ROC Curve, MESH: Carbon-13 Magnetic Resonance Spectroscopy, MESH: Discriminant Analysis, MESH: Fatty Acids, Volatile, MESH: Feces, MESH: Female, MESH: Humans, MESH: Least-Squares Analysis, MESH: Male, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

Relation: info:eu-repo/semantics/altIdentifier/pmid/33919750; hal-03358035; https://hal-amu.archives-ouvertes.fr/hal-03358035; PUBMED: 33919750; PUBMEDCENTRAL: PMC8070723

الاتاحة: https://hal-amu.archives-ouvertes.fr/hal-03358035
https://doi.org/10.3390/molecules26082266

المؤلفون: Jean-Luc Faucheron, Philippe Rouanet, Laurent Bresler, Denis Pezet, L. Mineur, M. Jafari, C Lemanski, Jacques Balosso, Marc Pocard, B Lelong, E. Rullier, J M Fabre, François Dravet, Michel Rivoire, Sophie Gourgou

المساهمون: Institut du Cancer de Montpellier (ICM), Centre Léon Bérard [Lyon], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), CHU Bordeaux [Bordeaux], Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Institut Sainte Catherine [Avignon], INSERM UMR-S 606, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, PRES Sorbonne Paris-Cité, and Université Paris Denis Diderot, Université Paris Diderot - Paris 7 (UPD7), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre René Gauducheau, CRLCC René Gauducheau, CHU Clermont-Ferrand, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)

المصدر: British Journal of Surgery
British Journal of Surgery, 2021, 108 (1), pp.10-13. ⟨10.1093/bjs/znaa010⟩

مصطلحات موضوعية: medicine.medical_specialty, MESH: Margins of Excision, medicine.medical_treatment, [SDV]Life Sciences [q-bio], MESH: Neoadjuvant Therapy, MEDLINE, Anal Canal, Kaplan-Meier Estimate, Adenocarcinoma, Preoperative care, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, medicine, Humans, Neoadjuvant therapy, Survival analysis, health care economics and organizations, MESH: Kaplan-Meier Estimate, MESH: Humans, Rectal Neoplasms, business.industry, Abdominoperineal resection, MESH: Anal Canal, MESH: Adenocarcinoma, Margins of Excision, MESH: Rectal Neoplasms, Survival Analysis, Neoadjuvant Therapy, Surgery, Clinical trial, medicine.anatomical_structure, 030220 oncology & carcinogenesis, MESH: Survival Analysis, MESH: Disease-Free Survival, Sphincter, 030211 gastroenterology & hepatology, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa0f52a85641c454ccc97a18b8e1f3d
https://hal.archives-ouvertes.fr/hal-03657636

المؤلفون: Luciana Molinero, Melinda L. Telli, Vidya Maiya, Hiroji Iwata, Kevin Punie, Mario Liste-Hermoso, Carlos H. Barrios, Andreas Koehler, Elizabeth A. Mittendorf, Frédérique Penault-Llorca, Shilpen Patel, Anh Nguyen Duc, Cristiano Ferrario, Joohyuk Sohn, Roberto Hegg, Shigehira Saji, Stephen Y. Chui, Kyung Hae Jung, Nadia Harbeck, Hong Zhang

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER

المصدر: The Lancet
The Lancet, Elsevier, 2020, 396 (10257), pp.1090-1100. ⟨10.1016/S0140-6736(20)31953-X⟩

مصطلحات موضوعية: medicine.medical_treatment, [SDV]Life Sciences [q-bio], Triple Negative Breast Neoplasms, 030204 cardiovascular system & hematology, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, MESH: Double-Blind Method, 030212 general & internal medicine, Neoadjuvant therapy, Triple-negative breast cancer, education.field_of_study, MESH: Middle Aged, General Medicine, MESH: Triple Negative Breast Neoplasms, Middle Aged, Neoadjuvant Therapy, 3. Good health, MESH: Antineoplastic Combined Chemotherapy Protocols, Female, medicine.drug, Adult, medicine.medical_specialty, Cyclophosphamide, Anthracycline, Paclitaxel, Population, MESH: Neoadjuvant Therapy, Antineoplastic Agents, Placebo, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, MESH: Doxorubicin, Double-Blind Method, Atezolizumab, Internal medicine, Albumins, Humans, MESH: Paclitaxel, education, Chemotherapy, MESH: Humans, business.industry, MESH: Cyclophosphamide, MESH: Adult, Doxorubicin, MESH: Antibodies, Monoclonal, Humanized, MESH: Antineoplastic Agents, MESH: Albumins, business, MESH: Female

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::221e52d5af8d01ad9b7f0473fadec775
https://hal.archives-ouvertes.fr/hal-03046446

المؤلفون: Gury, Lambert

المساهمون: Université de Paris - UFR Médecine Paris Centre [Santé] (UP Médecine Paris Centre), Université de Paris (UP), François Audenet

المصدر: Médecine humaine et pathologie. 2020

مصطلحات موضوعية: Clinical Evidence of Regional Lymph (cN+), Cystectomie totale, Radio-chimiothérapie, Chemoradiation, Muscle-Invasive Bladder Cancer (MIBC), MESH: Neoadjuvant Therapy, Radical Cystectomy, Tumeurs de vessie infiltrant le muscle (TVIM), Atteinte clinique des ganglions pelviens (cN+), Induction Chemotherapy, Chimiothérapie première, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, MESH: Chemoradiotherapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2592::a60357cc2119c17eefd83cc0151e0a94
https://dumas.ccsd.cnrs.fr/dumas-03464514/file/ThEXE_Lambert_Gury_DUMAS.pdf

المؤلفون: Anne Dubois, Jean-Jacques Tuech, Philippe Rouanet, M. Bertrand, Anne Rullier, Marc Pocard, Quentin Denost, Véronique Vendrely, Bertrand Trilling, Mehrdad Jafari, Alain Valverde, G. Portier, Cécile de Chaisemartin, Nora Frulio, Julien Asselineau, Eric Frison, Denis Smith, Eric Rullier, Bernard Meunier, Michel Rivoire, Igor Sieleznieff, Frédéric Marchal

المساهمون: Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], CIC Bordeaux, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle (ICM), CRLCC Val d'Aurelle - Paul Lamarque, Hôpital Charles Nicolle [Rouen], Groupe Hospitalier Diaconesses Croix Saint-Simon, Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre Léon Bérard [Lyon], Hôpital Michallon, Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université Lille Nord de France (COMUE)-UNICANCER, Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], CHU Pontchaillou [Rennes], Hôpital de la Timone [CHU - APHM] (TIMONE), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER, CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Pellegrin, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Salvy-Córdoba, Nathalie, Université de Lille-UNICANCER, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)

المصدر: The Lancet Gastroenterology and Hepatology
The Lancet Gastroenterology and Hepatology, Elsevier, 2020, 5 (5), pp.465-474. ⟨10.1016/S2468-1253(19)30410-8⟩
The Lancet Gastroenterology & Hepatology
The Lancet Gastroenterology & Hepatology, 2020, 5 (5), pp.465-474. ⟨10.1016/S2468-1253(19)30410-8⟩

مصطلحات موضوعية: medicine.medical_specialty, [SDV.MHEP.CHI] Life Sciences [q-bio]/Human health and pathology/Surgery, MESH: Survival Rate, MESH: Chemoradiotherapy, Adjuvant, Colorectal cancer, medicine.medical_treatment, MESH: Neoadjuvant Therapy, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, MESH: Intention to Treat Analysis, MESH: Proportional Hazards Models, 03 medical and health sciences, 0302 clinical medicine, MESH: Aged, 80 and over, [SDV.CAN] Life Sciences [q-bio]/Cancer, medicine, Prospective cohort study, Survival rate, Neoadjuvant therapy, MESH: Kaplan-Meier Estimate, MESH: Aged, Intention-to-treat analysis, MESH: Middle Aged, MESH: Humans, Hepatology, MESH: Organ Sparing Treatments, business.industry, MESH: Proctectomy, Hazard ratio, Gastroenterology, MESH: Rectal Neoplasms, MESH: Adult, MESH: Neoplasm Staging, medicine.disease, Total mesorectal excision, MESH: Neoplasm Metastasis, MESH: Prospective Studies, MESH: Male, 3. Good health, Surgery, 030220 oncology & carcinogenesis, MESH: Disease-Free Survival, 030211 gastroenterology & hepatology, business, MESH: Neoplasm Recurrence, Local, MESH: Female, Chemoradiotherapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f8da1081b07e9eba901accb3a0227c
https://hal.umontpellier.fr/hal-03350581

المؤلفون: de Cremoux, Patricia, Valet, Fabien, Gentien, David, Lehmann-Che, Jacqueline, Scott, Véronique, Tran-Perennou, Carine, Barbaroux, Catherine, Servant, Nicolas, Vacher, Sophie, Sigal-Zafrani, Brigitte, Mathieu, Marie-Christine, Bertheau, Philippe, Guinebretière, Jean-Marc, Asselain, Bernard, Marty, Michel, Spyratos, Frédérique

المساهمون: Département de Biologie des Tumeurs, Institut Curie Paris, Cancer et génome: Bioinformatique, biostatistiques et épidémiologie d'un système complexe, Mines Paris - PSL (École nationale supérieure des mines de Paris), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Département de biostatistiques, Département de Recherche Translationnelle, Département de biochimie Saint-Louis, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de recherche translationnelle, Direction de la recherche Gustave Roussy, Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Service de Génétique Oncologique, Département de biologie et pathologie médicales Gustave Roussy, Institut Gustave Roussy (IGR), Service d'anatomo-pathologie Paris, Hôpital René Huguenin Saint-Cloud, Institut Curie - Saint Cloud (ICSC), Centre des Innovations Thérapeutiques en Oncologie et Hématologie, This work was supported by academic grants (PHRC AOM/2OO2/02117) and industrial grants from Pfizer inc., Roche, Sanofi-Aventis.ISRCTN10059974.

المصدر: ISSN: 1471-2407.

مصطلحات موضوعية: neoadjuvant setting, transcriptome, RT-qPCR, breast cancer, quality criteria, MESH: Antineoplastic Agents, MESH: Breast Neoplasms, MESH: Research Design, MESH: Reverse Transcriptase Polymerase Chain Reaction, MESH: Chemotherapy, Adjuvant, MESH: Cluster Analysis, MESH: Female, MESH: Gene Expression Profiling, MESH: Gene Expression Regulation, Neoplastic, MESH: Humans, MESH: Neoadjuvant Therapy, MESH: Reproducibility of Results, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/21631949; inserm-00663653; https://inserm.hal.science/inserm-00663653; https://inserm.hal.science/inserm-00663653/document; https://inserm.hal.science/inserm-00663653/file/1471-2407-11-215.pdf; PUBMED: 21631949

الاتاحة: https://inserm.hal.science/inserm-00663653
https://inserm.hal.science/inserm-00663653/document
https://inserm.hal.science/inserm-00663653/file/1471-2407-11-215.pdf
https://doi.org/10.1186/1471-2407-11-215

المؤلفون: Ando, Kosei, Mori, Kanji, Corradini, Nadège, Redini, Françoise, Heymann, Dominique

المساهمون: Physiopathologie des Adaptations Nutritionnelles (PhAN), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Department of Orthopaedic Surgery, Shiga University of Medical Science, Service d'oncologie pédiatrique, Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Pôle Biologie

المصدر: ISSN: 1465-6566.

مصطلحات موضوعية: osteosarcoma, liposomal muramyl tripeptide phosphatidylethanolamine, mifamurtide, macrophage, chemotherapy, innate immunity, MESH: Acetylmuramyl-Alanyl-Isoglutamine, MESH: Adjuvants, Immunologic, MESH: Antineoplastic Agents, MESH: Bone Neoplasms, MESH: Disease Progression, MESH: Humans, MESH: Neoadjuvant Therapy, MESH: Osteosarcoma, MESH: Phosphatidylethanolamines, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system

Relation: info:eu-repo/semantics/altIdentifier/pmid/21226638; inserm-00667530; https://inserm.hal.science/inserm-00667530; https://inserm.hal.science/inserm-00667530/document; https://inserm.hal.science/inserm-00667530/file/Ando_et_al.pdf; https://inserm.hal.science/inserm-00667530/file/inserm-00667530_edited.pdf; PUBMED: 21226638

الاتاحة: https://inserm.hal.science/inserm-00667530
https://inserm.hal.science/inserm-00667530/document
https://inserm.hal.science/inserm-00667530/file/Ando_et_al.pdf
https://inserm.hal.science/inserm-00667530/file/inserm-00667530_edited.pdf
https://doi.org/10.1517/14656566.2011.543129

المؤلفون: Mittendorf, Elizabeth, A, Hong, Zhang, H Barrios, Carlos, Saji, Shigehira, Jung, Kyung Hae, Hegg, Roberto, Koehler, Andreas, Sohn, Joohyuk, Iwata, Hiroji, L Telli, Melinda, Ferrario, Cristiano, Punie, Kevin, Penault Llorca, Frédérique, Patel, Shilpen, Nguyen, Duc Anh, Liste-Hermoso, Mario, Maiya, Vidya, Molinero, Luciana, y Chui, Stephen, Harbeck, Nadia

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne 2017-2020 (UCA 2017-2020 ), Centre Jean Perrin Clermont-Ferrand (UNICANCER/CJP), UNICANCER

المصدر: ISSN: 0140-6736.

مصطلحات موضوعية: MESH: Adult, MESH: Albumins, MESH: Middle Aged, MESH: Neoadjuvant Therapy, MESH: Paclitaxel, MESH: Triple Negative Breast Neoplasms, MESH: Antibodies, Monoclonal, Humanized, MESH: Antineoplastic Agents, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Cyclophosphamide, MESH: Double-Blind Method, MESH: Doxorubicin, MESH: Female, MESH: Humans, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/32966830; hal-03046446; https://hal.science/hal-03046446; PUBMED: 32966830

الاتاحة: https://hal.science/hal-03046446
https://doi.org/10.1016/S0140-6736(20)31953-X

المؤلفون: Piperno-Neumann, Sophie, Ray-Coquard, Isabelle, Occean, Bob-Valéry, Laurence, Valérie, Cupissol, Didier, Perrin, Christophe, Penel, Nicolas, Bompas, Emmanuelle, Rios, Maria, Le Cesne, Axel, Italiano, Antoine, Anract, Philippe, De Pinieux, Gonzague, Collard, Olivier, Bertucci, François, Duffaud, Florence, Le Deley, Marie-Cécile, Delaye, Jessy, Brugières, Laurence, Blay, Jean-Yves, Piperno‐Neumann, Sophie, Ray‐Coquard, Isabelle, Occean, Bob‐Valéry, Pinieux, Gonzague, Le Deley, Marie‐Cécile, Blay, Jean‐Yves

المساهمون: Institut Curie [Paris], Centre Léon Bérard [Lyon], Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Département d'Oncologie Médicale [Institut Curie, Paris], Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université Lille Nord de France (COMUE)-UNICANCER, Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR), Institut Bergonié [Bordeaux], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Trousseau, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre de Recherche en Cancérologie de Marseille (CRCM), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Service d’Oncologie Médicale [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), UNICANCER [Paris], Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Département de cancérologie de l'enfant et de l'adolescent [Gustave Roussy], Service d'Oncologie Médicale, Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Lille-UNICANCER, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: International Journal of Cancer
International Journal of Cancer, Wiley, 2019, 146 (2), pp.413-423. ⟨10.1002/ijc.32526⟩
International Journal of Cancer, 2019, 146 (2), pp.413-423. ⟨10.1002/ijc.32526⟩

مصطلحات موضوعية: Male, Cancer Research, MESH: Osteosarcoma, [SDV]Life Sciences [q-bio], adult patients, Kaplan-Meier Estimate, Zoledronic Acid, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Etoposide, MESH: Etoposide, MESH: Aged, MESH: Middle Aged, MESH: Follow-Up Studies, Middle Aged, Prognosis, MESH: Bone Neoplasms, Neoadjuvant Therapy, 3. Good health, Survival Rate, MESH: Antineoplastic Combined Chemotherapy Protocols, MESH: Methotrexate, Oncology, MESH: Young Adult, 030220 oncology & carcinogenesis, Toxicity, Osteosarcoma, Female, France, Primary tumour size, medicine.drug, Adult, medicine.medical_specialty, Adolescent, MESH: Survival Rate, MESH: Neoadjuvant Therapy, Bone Neoplasms, Subgroup analysis, doxorubicin-cisplatin-ifosfamide regimen, MESH: Zoledronic Acid, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, MESH: Drug Administration Schedule, Disease-Free Survival, Drug Administration Schedule, MESH: Prognosis, Young Adult, 03 medical and health sciences, MESH: Doxorubicin, Internal medicine, osteosarcoma, medicine, Humans, Ifosfamide, MESH: Ifosfamide, MESH: Kaplan-Meier Estimate, Aged, MESH: Adolescent, MESH: Humans, Adult patients, business.industry, MESH: Adult, medicine.disease, Acute toxicity, MESH: Male, MESH: France, Regimen, Methotrexate, MESH: Cisplatin, Doxorubicin, MESH: Disease-Free Survival, Feasibility Studies, Cisplatin, business, MESH: Feasibility Studies, MESH: Female, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e950760137dbb4818b390e785754ca7
https://hal.archives-ouvertes.fr/hal-02530602

المؤلفون: Gury, Lambert

المساهمون: UFR Médecine Santé - Université Paris Cité (UFR Médecine UPCité), Université Paris Cité (UPCité), François Audenet

المصدر: https://dumas.ccsd.cnrs.fr/dumas-03464514 ; Médecine humaine et pathologie. 2020.

مصطلحات موضوعية: Muscle-Invasive Bladder Cancer (MIBC), Clinical Evidence of Regional Lymph (cN+), Radical Cystectomy, Induction Chemotherapy, Chemoradiation, Tumeurs de vessie infiltrant le muscle (TVIM), Atteinte clinique des ganglions pelviens (cN+), Cystectomie totale, Chimiothérapie première, Radio-chimiothérapie, MESH: Chemoradiotherapy, MESH: Neoadjuvant Therapy, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Relation: dumas-03464514; https://dumas.ccsd.cnrs.fr/dumas-03464514; https://dumas.ccsd.cnrs.fr/dumas-03464514/document; https://dumas.ccsd.cnrs.fr/dumas-03464514/file/ThEXE_Lambert_Gury_DUMAS.pdf

الاتاحة: https://dumas.ccsd.cnrs.fr/dumas-03464514
https://dumas.ccsd.cnrs.fr/dumas-03464514/document
https://dumas.ccsd.cnrs.fr/dumas-03464514/file/ThEXE_Lambert_Gury_DUMAS.pdf

المؤلفون: Wen, Patrick, Touat, Mehdi, Alexander, Brian, Mellinghoff, Ingo, Ramkissoon, Shakti, Mccluskey, Christine, Pelton, Kristine, Haidar, Sam, Basu, Sankha, Gaffey, Sarah, Brown, Loreal, Martinez-Ledesma, Juan Emmanuel, Wu, Shaofang, Kim, Jungwoo, Wei, Wei, Park, Mi-Ae, Huse, Jason, Kuhn, John, Rinne, Mikael, Colman, Howard, Agar, Nathalie, Omuro, Antonio, Deangelis, Lisa, Gilbert, Mark, de Groot, John, Cloughesy, Timothy, Chi, Andrew, Roberts, Thomas, Zhao, Jean, Lee, Eudocia, Nayak, Lakshmi, Heath, James, Horky, Laura, Batchelor, Tracy, Beroukhim, Rameen, Chang, Susan, Ligon, Azra, Dunn, Ian, Koul, Dimpy, Young, Geoffrey, Prados, Michael, Reardon, David, Yung, W.K. Alfred, Ligon, Keith

المساهمون: Dana-Farber Cancer Institute Boston, Brigham and Women's Hospital Boston, Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Memorial Sloane Kettering Cancer Center New York, The University of Texas M.D. Anderson Cancer Center Houston, California Institute of Technology (CALTECH), David Geffen School of Medicine Los Angeles, University of California Los Angeles (UCLA), University of California (UC)-University of California (UC), Institute for Systems Biology Seattle (ISB), The University of Texas at San Antonio (UTSA), Huntsman Cancer Institute Salt Lake City, University of Utah, New York University School of Medicine, NYU System (NYU), Massachusetts General Hospital Boston, University of California San Francisco (UC San Francisco), University of California (UC)

المصدر: ISSN: 0732-183X.

مصطلحات موضوعية: MESH: Adult, MESH: Aged, MESH: Glioblastoma, MESH: Humans, MESH: Male, MESH: Middle Aged, MESH: Morpholines, MESH: Neoadjuvant Therapy, MESH: Neoplasm Recurrence, Local, MESH: Phosphatidylinositol 3-Kinase, MESH: Phosphoinositide-3 Kinase Inhibitors, MESH: Progression-Free Survival, 80 and over, MESH: Time Factors, MESH: Aminopyridines, MESH: Antineoplastic Agents, MESH: Brain Neoplasms, MESH: Chemotherapy, Adjuvant, MESH: Disease Progression, MESH: Enzyme Activation, MESH: Female, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/30715997; hal-04555735; https://hal.sorbonne-universite.fr/hal-04555735; PUBMED: 30715997; PUBMEDCENTRAL: PMC6553812

الاتاحة: https://hal.sorbonne-universite.fr/hal-04555735
https://doi.org/10.1200/JCO.18.01207

المؤلفون: Lieven Pouillon, P. van Dam, Peter B. Vermeulen, Cecile Colpaert, S. Van Laere, Mark M. Kockx, K. A. Schats, C. Van Berckelaer, François Bertucci, C. Rypens, Luc Dirix, M. Parizel, Wiebren A.A. Tjalma

المساهمون: Centre de Recherche en Cancérologie de Marseille (CRCM), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Department of Medical Oncology, St-Augustinus, Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Breast cancer research
Breast Cancer Research
Breast Cancer Research, BioMed Central, 2019, 21 (1), pp.28. ⟨10.1186/s13058-019-1108-1⟩
Breast Cancer Research, Vol 21, Iss 1, Pp 1-12 (2019)
Breast Cancer Research : BCR
Breast Cancer Research, 2019, 21 (1), pp.28. ⟨10.1186/s13058-019-1108-1⟩

مصطلحات موضوعية: Oncology, MESH: Mastectomy, [SDV]Life Sciences [q-bio], CD8-Positive T-Lymphocytes, B7-H1 Antigen, 0302 clinical medicine, MESH: Aged, 80 and over, Surgical oncology, Antineoplastic Combined Chemotherapy Protocols, MESH: B7-H1 Antigen, MESH: Lymphocytes, Tumor-Infiltrating, skin and connective tissue diseases, Mastectomy, Aged, 80 and over, MESH: Aged, MESH: Middle Aged, Inflammatory breast cancer (IBC), Immune checkpoint modulators, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, MESH: CD8-Positive T-Lymphocytes, Neoadjuvant Therapy, 3. Good health, MESH: Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, MESH: Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, MESH: Survival Analysis, Cohort, Stromal tumour-infiltrating lymphocytes (sTIL), MESH: Inflammatory Breast Neoplasms, Female, Inflammatory Breast Neoplasms, Research Article, Adult, medicine.medical_specialty, Stromal cell, Programmed death-ligand 1 (PD-L1), MESH: Neoadjuvant Therapy, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Inflammatory breast cancer, lcsh:RC254-282, Disease-Free Survival, MESH: Prognosis, 03 medical and health sciences, Immune system, Breast cancer, Lymphocytes, Tumor-Infiltrating, Stroma, Internal medicine, medicine, Adjuvant therapy, Humans, Immune response, Aged, MESH: Humans, business.industry, MESH: Adult, medicine.disease, Survival Analysis, MESH: Disease-Free Survival, Human medicine, Stromal Cells, MESH: Stromal Cells, business, MESH: Female

وصف الملف: pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969058f90fb7675681eaa7b0d4b0ab58
https://repository.uantwerpen.be/docman/irua/fdb529/157356.pdf

المؤلفون: Patrice Taourel, David Azria, E. Pages, Céline Bourgier, William Jacot, P. Rouanet, P. Crochet, Ingrid Millet

المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut Montpelliérain Alexander Grothendieck (IMAG), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)

المصدر: Critical Reviews in Oncology/Hematology
Critical Reviews in Oncology/Hematology, Elsevier, 2018, 132, pp.51-65. ⟨10.1016/j.critrevonc.2018.09.012⟩

مصطلحات موضوعية: In vivo magnetic resonance spectroscopy, medicine.medical_specialty, medicine.medical_treatment, MESH: Neoadjuvant Therapy, Context (language use), Breast Neoplasms, MESH: Lymph Nodes, [SDV.CAN]Life Sciences [q-bio]/Cancer, Disease, MESH: Disease Management, 030218 nuclear medicine & medical imaging, MESH: Magnetic Resonance Imaging, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, medicine, Breast MRI, Humans, Lymph node, Neoplasm Staging, Chemotherapy, MESH: Humans, medicine.diagnostic_test, business.industry, Disease Management, Magnetic resonance imaging, Neo-adjuvant chemotherapy, Hematology, MESH: Neoplasm Staging, medicine.disease, Magnetic Resonance Imaging, Neoadjuvant Therapy, 3. Good health, medicine.anatomical_structure, Oncology, Chemotherapy, Adjuvant, MESH: Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Radiology, Lymph Nodes, business, MESH: Female, MESH: Breast Neoplasms, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, MRI

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a06f91cd19cc3572d7332f1161e4b87
https://hal.umontpellier.fr/hal-02292738